Proven safe and effective

The safety and efficacy of Privigen were studied in PI, CIDP, and chronic ITP. See the results.

The right treatment for the right patient

Hear some success stories of patients treated with Privigen from PI experts Carla Duff, ARNP*, and Mark Stein, MD.

*Carla Duff is currently an employee of CSL Behring. When this video was produced, Ms. Duff was an Advanced Registered Nurse Practitioner with John Hopkins All Children Hospital in Saint Petersburg, Florida.

Privigen is the first and only IVIg stabilized with proline

Stabilized with proline

Proline was specifically chosen after extensive testing and analysis.

CSL Behring has a heritage of excellence

A heritage of excellence and innovation in plasma therapy

CSL Behring has been fractionating human plasma for more than 65 years, employing an expert team of virologists and quality assurance systems and controls that are among the most rigorous and comprehensive in the industry.

  • CSL Behring's Ig products are manufactured at state-of-the-art locations in Bern, Switzerland; Marburg, Germany; Broadmeadows, Australia; and Kankakee, Illinois, USA
  • We also operate CSL Plasma, one of the world's largest plasma collection networks with more than 300 collection centers throughout the United States, Europe, and China.

Additional manufacturing process to help reinforce quality

The manufacturing process for Privigen has been modified to include an immunoaffinity chromatography step called Ig IsoLo® that reduces levels of anti-A and anti-B antibodies while still retaining other beneficial components.

You are now leaving the current website.

Do you want to continue?